Publications:

CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients.

Aids (London, England)

Kwara, Awewura A; Lartey, Margaret M; Sagoe, Kwamena W C KW; Kenu, Ernest E; Court, Michael H MH

Publication Date: 2009-10-23

Variant appearance in text: CYP2B6: M365V

PubMed Link: 19779319

Variant Present in the following documents:

• Main text

View BVdb publication page

CYP2B6 (c.516G-->T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients.

British Journal Of Clinical Pharmacology

Kwara, Awewura A; Lartey, Margaret M; Sagoe, Kwamena W KW; Rzek, Naser L NL; Court, Michael H MH

Publication Date: 2009-04

Variant appearance in text: CYP2B6: M365V

PubMed Link: 19371316

Variant Present in the following documents:

• Main text

View BVdb publication page